News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
U.S. Clears Novartis AG Malaria Drug, Awards Voucher
April 8, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, April 8 (Reuters) - U.S. health officials approved a Novartis AG (NOVN.VX) malaria drug on Wednesday and awarded the company a voucher to speed approval of a future medicine.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Novartis
MORE ON THIS TOPIC
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
February 18, 2026
·
1 min read
·
Heather McKenzie
Rare disease
Disc’s Regulatory Comeback Plan for Rejected Drug Relies on Old FDA Leadership
February 17, 2026
·
3 min read
·
Annalee Armstrong
Podcast
As FDA Moves Away From Animal Testing, AI and Organoids Can Shine
February 17, 2026
·
1 min read
·
Jef Akst
FDA
Moderna’s mRNA Vaccine Refusal Comes Amid Global Advanced Therapies Push
February 17, 2026
·
5 min read
·
Heather McKenzie
